Rahmath, M.R.K.; Ibrahim, H.; Faiyaz-Ul-Haque, M.; Nawaz, Z.; Zitoun, A.; Hussein, A.; Sadek, A.; El-Menyar, A.; Kamal, R.; Al-Thani, H.;
et al. Understanding the Spectrum of Mild Clinical Outcomes and Novel Findings in Arterial Tortuosity Syndrome Among Qatari Patients: Implications of SLC2A10 Mutation. Biomedicines 2025, 13, 159.
https://doi.org/10.3390/biomedicines13010159
AMA Style
Rahmath MRK, Ibrahim H, Faiyaz-Ul-Haque M, Nawaz Z, Zitoun A, Hussein A, Sadek A, El-Menyar A, Kamal R, Al-Thani H,
et al. Understanding the Spectrum of Mild Clinical Outcomes and Novel Findings in Arterial Tortuosity Syndrome Among Qatari Patients: Implications of SLC2A10 Mutation. Biomedicines. 2025; 13(1):159.
https://doi.org/10.3390/biomedicines13010159
Chicago/Turabian Style
Rahmath, Muhammed Riyas K., Haytham Ibrahim, Muhammad Faiyaz-Ul-Haque, Zafar Nawaz, Ahmad Zitoun, Ahmed Hussein, Ahmed Sadek, Ayman El-Menyar, Reema Kamal, Hassan Al-Thani,
and et al. 2025. "Understanding the Spectrum of Mild Clinical Outcomes and Novel Findings in Arterial Tortuosity Syndrome Among Qatari Patients: Implications of SLC2A10 Mutation" Biomedicines 13, no. 1: 159.
https://doi.org/10.3390/biomedicines13010159
APA Style
Rahmath, M. R. K., Ibrahim, H., Faiyaz-Ul-Haque, M., Nawaz, Z., Zitoun, A., Hussein, A., Sadek, A., El-Menyar, A., Kamal, R., Al-Thani, H., & Sher, G.
(2025). Understanding the Spectrum of Mild Clinical Outcomes and Novel Findings in Arterial Tortuosity Syndrome Among Qatari Patients: Implications of SLC2A10 Mutation. Biomedicines, 13(1), 159.
https://doi.org/10.3390/biomedicines13010159
